Management of acute coronary syndromes: Special considerations in women

Heart

Volumn 103, Issue 20, 2017, Pages 1638-1646

  Madonis, Stephanie M ^a   Skelding, Kimberly A ^a   Roberts, Madhur ^b  

^a GEISINGER MEDICAL CENTER   (United States)

^b PIEDMONT HEART INSTITUTE   (United States)

Author keywords

acute coronary syndrome; sex related differences; treatment disparities; women

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRASUGREL; TICAGRELOR;

ACUTE CORONARY SYNDROME; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DEVELOPING COUNTRY; EVIDENCE BASED PRACTICE; HEART MUSCLE REPERFUSION; HEART REHABILITATION; HORMONE SUBSTITUTION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; TREATMENT OUTCOME; DISEASE MANAGEMENT; FEMALE; MORBIDITY; REGISTER; SURVIVAL RATE;

ACUTE CORONARY SYNDROME; DISEASE MANAGEMENT; FEMALE; HUMANS; MORBIDITY; REGISTRIES; SURVIVAL RATE;

EID: 85030652178     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2016-309938     Document Type: Article

References (97)

1. Kochanek KD, Murphy SL, Xu J, et al. Deaths: final data for 2014. National Vital Statistics Report., 2016:65, 1-122.
2. Graham G. Acute coronary syndromes in women: recent treatment trends and outcomes. Clin Med Insights Cardiol 2016;10:1-10.
3. Cook NR, Paynter NP, Eaton CB, et al. Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative. Circulation 2012;125:1748S1-1756S11.
4. Pepine CJ, Ferdinand KC, Shaw LJ, et al. Emergence of nonobstructive coronary artery disease: a Woman's Problem and Need for Change in Definition on Angiography. J Am Coll Cardiol 2015;66:1918-33.
5. Reynolds HR, Srichai MB, Iqbal SN, et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation 2011;124:1414-25.
6. Stramba-Badiale M, Fox KM, Priori SG, et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 2006;27:994-1005.
7. Bugiardini R, Bairey Merz CN. Angina with "normal" coronary arteries: a changing philosophy. JAMA 2005;293:477-84.
8. Chokshi NP, Iqbal SN, Berger RL, et al. Sex and race are associated with the absence of epicardial coronary artery obstructive disease at angiography in patients with acute coronary syndromes. Clin Cardiol 2010;33:495-501.
9. Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease. A report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Int Med 2009;169:844-50.
10. Shaw LJ, Bairey Merz CN, Pepine CJ, et al. Insights from the NHLBI-Sponsored Women?s ischemia syndrome evaluation (WISE) Study. J Am Coll Cardiol 2006;47:S4-S20.
11. Pepine CJ, Kerensky RA, Lambert CR, et al. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol 2006;47(3 Suppl):S30-S35.
12. Han SH, Bae JH, Holmes DR, et al. Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis. Eur Heart J 2008;29:1359-69.
13. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core. Circulation 1996;93:1354-63.
14. Guagliumi G, Capodanno D, Saia F, et al. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study. JACC Cardiovasc Interv 2014;7:958-68.
15. Saia F, Komukai K, Capodanno D, et al. Eroded Versus Ruptured Plaques at the culprit site of STEMI: in Vivo Pathophysiological features and response to primary PCI. JACC Cardiovasc Imaging 2015;8-566-75.
16. Nguyen HL, Saczynski JS, Gore JM, et al. Age and sex differences in duration of prehospital delay in patients with acute myocardial infarction: a systematic review. Circ Cardiovasc Qual Outcomes 2010;3:82-92.
17. Milner KA, Funk M, Richards S, et al. Gender differences in symptom presentation associated with coronary heart disease. Am J Cardiol 1999;84:396-9.
18. Pilote L, Karp I, Genesis-praxy KI. GENESIS-PRAXY (GENdEr and sex determInantS of cardiovascular disease: from bench to beyond-Premature acute coronary SYndrome). Am Heart J 2012;163:741-6.
19. O'Donoghue M, Boden WE, Braunwald E, et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA 2008;300:71-80.
20. Wiviott SD, Cannon CP, Morrow DA, et al. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine cost of therapy with an invasive or conservative Strategy-Thrombolysis in myocardial infarction 18) substudy. Circulation 2004;109:580-6.
21. Shah AS, Griffiths M, Lee KK, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ 2015;350:g7873.
22. Rosengren A, Wallentin L, K Gitt A, et al. Sex, age, and clinical presentation of acute coronary syndromes. Eur Heart J 2004;25:663-70.
23. Simon T, Mary-Krause M, Cambou JP, et al. Impact of age and gender on in-hospital and late mortality after acute myocardial infarction: increased early risk in younger women: results from the french nation-wide USIC registries. Eur Heart J 2006;27:1282-8.
24. Shavelle DM, Rasouli ML, Frederick P, et al. National Registry of Myocardial Infarction investigators. outcome in patients transferred for Percutaneous Coronary intervention (a National registry of Myocardial infarction 2/3/4 analysis). Am J Cardiol 2005;96:1227-32.
25. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-e151.
26. Goldberg RJ, Gorak EJ, Yarzebski J, et al. A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-ofhospital deaths caused by coronary heart disease. Circulation 1993;87:1947-53.
27. Alter DA, Naylor CD, Austin PC, et al. Biology or Bias: practice patterns and long-term outcomes for men and women with acute myocardial infarction. J Am Coll Cardiol 2002;39:1909-16.
28. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-11.
29. Hermenegildo C, Oviedo PJ, Cano A. Cyclooxygenases regulation by estradiol on endothelium. Curr Pharm Des 2006;12:205-15.
30. Rosano GM, Vitale C, Marazzi G, et al. Menopause and cardiovascular disease: the evidence. Climacteric 2007;10 Suppl 1:19-24.
31. Taddei S, Virdis A, Ghiadoni L, et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996;28:576-82.
32. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/ progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-13.
33. Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000;343:522-9.
34. Humphrey LL, Chan BK, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med 2002;137:273-84.
35. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
36. Alexander KP, Newby LK, Hellkamp AS, et al. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol 2001;38:1-7.
37. Tanis BC, van den Bosch MA, Kemmeren JM, et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med 2001;345:1787-93.
38. James AH, Jamison MG, Biswas MS, et al. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 2006;113:1564-71.
39. Stone GW, Grines CL, Browne KF, et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the primary angioplasty in myocardial infarction (PAMI) trail. J Am Coll Cardiol 1995;25:370-7.
40. Akhter N, Milford-Beland S, Roe MT, et al. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Am Heart J 2009;157:141-8.
41. Berger JS, Sanborn TA, Sherman W, et al. Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention. Am Heart J 2006;151:1026-31.
42. Duvernoy CS, Smith DE, Manohar P, et al. Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry. Am Heart J 2010;159:677-83.
43. Tamis-Holland JE, Palazzo A, Stebbins AL, et al. Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the global use of strategies to open occluded arteries in acute coronary syndromes angioplasty (GUSTO II-B) Angioplasty substudy. Am Heart J 2004;147:133-9.
44. Dolor RJ, Melloni C, Chatterjee R, et al. AHRQ comparative effectiveness reviews, in treatment strategies for women with coronary artery disease. Rockville, MD: Agency for Healthcare Reseach and Quality (US), 2012.
45. Glaser R, Herrmann HC, Murphy SA, et al. Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA 2002;288:3124-9.
46. Anderson RD, Pepine CJ. Gender differences in the treatment for acute myocardial infarction: bias or biology? Circulation 2007;115:823-6.
47. Mikhail GW. Coronary revascularisation in women. Heart 2006;92(suppl-3):iii19-iii23.
48. Redberg RF. Gender differences in acute coronary syndrome: invasive versus conservative approach. Cardiol Rev 2006;14:299-302.
49. Jneid H, Fonarow GC, Cannon CP, et al. Sex differences in medical care and early death after acute myocardial infarction. Circulation 2008;118:2803-10.
50. Radovanovic D, Auer M, Erne P, et al. Sex-related differences in treatment and outcome in patients with ACS. Cardiol Rev 2008;25:21-6.
51. Kim LK, Looser P, Swaminathan RV, et al. Sex-Based disparities in incidence, treatment, and outcomes of cardiac arrest in the United States, 2003-2012. J Am Heart Assoc 2016;5:e003704.
52. Foody JM. Differences in treatment and outcomes in women with ACS. Cardiol Rev 2008.
53. Lansky AJ, Hochman JS, Ward PA, et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women. Circulation 2005;111:940-53.
54. Deaton C, Kunik CL, Hachamovitch R, et al. Diagnostic strategies for women with suspected coronary artery disease. J Cardiovasc Nurs 2001;15:39-53.
55. Dreyer RP, Beltrame JF, Tavella R, et al. Evaluation of gender differences in Door-to-Balloon time in ST-elevation myocardial infarction. Heart Lung Circ 2013;22:861-9.
56. Bangalore S, Fonarow GC, Peterson ED, et al. Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. Am J Med 2012;125:1000-9.
57. D'Onofrio G, Safdar B, Lichtman JH, et al. Sex differences in reperfusion in Young Patients with ST-Segment-Elevation myocardial infarction: results from the VIRGO Study. Circulation 2015;131:1324-32.
58. Anand SS, Xie CC, Mehta S, et al. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol 2005;46:1845-51.
59. Bolooki H, Vargas A, Green R, et al. Results of direct coronary artery surgery in women. J Thorac Cardiovasc Surg 1975;69:271-7.
60. Myers WO, Davis K, Foster ED, et al. Surgical survival in the coronary artery surgery study (CASS) registry. Ann Thorac Surg 1985;40:245-60.
61. Jacobs AK, Kelsey SF, Brooks MM, et al. Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI). Circulation 1998;98:1279-85.
62. Mikhail GW. Coronary revascularisation in women. Heart 2006;92 Suppl 3:iii19-iii23.
63. Nguyen JT, Berger AK, Duval S, et al. Gender disparity in cardiac procedures and medication use for acute myocardial infarction. Am Heart J 2008;155:862-8.
64. Weaver WD, White HD, Wilcox RG, et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. JAMA 1996;275:777-82.
65. Wang TY, Angiolillo DJ, Cushman M, et al. Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease. J Am Coll Cardiol 2012;59:891-900.
66. Blomkalns AL, Chen AY, Hochman JS, et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can rapid risk stratification of unstable Angina Patients Suppress adverse outcomes with early implementation of the American College of Cardiology/American Heart Association guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 2005;45:832-7.
67. Alexander KP, Chen AY, Newby LK, et al. Sex differences in Major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can rapid risk stratification of unstable angina patients suppress ADverse outcomes with early implementation of the ACC/AHA guidelines) initiative. Circulation 2006;114:1380-7.
68. Pristipino C, Pelliccia F, Granatelli A, et al. Comparison of accessrelated bleeding complications in women versus men undergoing percutaneous coronary catheterization using the radial versus femoral artery. Am J Cardiol 2007;99:1216-21.
69. Saito S, Ikei H, Hosokawa G, et al. Influence of the ratio between radial artery inner diameter and sheath outer diameter on radial artery flow after transradial coronary intervention. Catheter Cardiovasc Interv 1999;46:173-8.
70. Sheifer SE, Canos MR, Weinfurt KP, et al. Sex differences in coronary artery size assessed by intravascular ultrasound. Am Heart J 2000;139:649-52.
71. Pandie S, Mehta SR, Cantor WJ, et al. Radial Versus Femoral access for coronary Angiography/Intervention in Women With Acute Coronary Syndromes: Insights From the RIVAL Trial (Radial Vs femorAL access for coronary intervention). JACC Cardiovasc Interv 2015;8:505-12.
72. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol 2007;49:1230-50.
73. Pilote L, Dasgupta K, Guru V, et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 2007;176:S1-S44.
74. Davis KB, Chaitman B, Ryan T, et al. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. coronary artery surgery study. J Am Coll Cardiol 1995;25:1000-9.
75. Bangalore S, Fonarow GC, Peterson ED, et al. Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. Am J Med 2012;125:1000-9.
76. Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol 2009;54:1561-75.
77. Anand SS, Xie CC, Mehta S, et al. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol 2005;46:1845-51.
78. Moriel M, Tzivoni D, Behar S, et al. Contemporary treatment and adherence to guidelines in women and men with acute coronary syndromes. Int J Cardiol 2008;131:97-104.
79. Smolina K, Ball L, Humphries KH, et al. Sex disparities in Post-Acute Myocardial Infarction pharmacologic treatment initiation and adherence: problem for Young Women. Circ Cardiovasc Qual Outcomes 2015;8:CIRCOUTCOMES. 115. 001987-92.
80. Bugiardini R, Yan AT, Yan RT, et al. Factors influencing underutilization of evidence-based therapies in women. Eur Heart J 2011;32:1337-44.
81. Bairey Merz CN, Mark S, Boyan BD, et al. Proceedings from the scientific symposium: sex differences in cardiovascular disease and implications for therapies. J Womens Health 2010;19:1059-72.
82. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
83. Xhyheri B, Bugiardini R. Diagnosis and treatment of heart disease: are women different from men? Prog Cardiovasc Dis 2010;53:227-36.
84. Vittinghoff E, Shlipak MG, Varosy PD, et al. Risk factors and secondary prevention in women with heart disease: the Heart and estrogen/progestin Replacement Study. Ann Intern Med 2003;138:81-9.
85. Shen H, Herzog W, Drolet M, et al. Aspirin resistance in healthy drug-naive men versus women (from the heredity and phenotype intervention Heart Study). Am J Cardiol 2009;104:606-12.
86. Yusuf S, Mehta SR, Zhao F, et al. Clopidogrel in unstable angina to prevent recurrent events trial investigators. early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 2003;107:966-72.
87. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study investigators. N Engl J Med 1998;339:1665-71.
88. Steinhubl SR, Berger PB, Mann JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20.
89. Berger JS, Bhatt DL, Cannon CP, et al. The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis. J Am Coll Cardiol 2009; 54:1935-45.
90. Husted S, James SK, Bach RG, et al. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient outcomes (PLATO) trial. Eur Heart J 2014;35:1541-50.
91. Feola M, Garnero S, Daniele B, et al. Gender differences in the efficacy of cardiovascular rehabilitation in patients after cardiac surgery procedures. J Geriatr Cardiol 2015;12:575-9.
92. Halm M, Penque S, Doll N, et al. Women and cardiac rehabilitation: referral and compliance patterns. J Cardiovasc Nurs 1999;13:83-92.
93. Colella TJ, Gravely S, Marzolini S, et al. Sex Bias in referral of women to outpatient cardiac rehabilitation? A meta-analysis. Eur J Prev Cardiol 2015;22:423-41.
94. Gee MA, Viera AJ, Miller PF, et al. Functional capacity in men and women following cardiac rehabilitation. J Cardiopulm Rehabil Prev 2014;34:255-62.
95. Colbert JD, Martin BJ, Haykowsky MJ, et al. Cardiac rehabilitation referral, attendance and mortality in women. Eur J Prev Cardiol 2015;22:979-86.
96. Shehab A, Al-Dabbagh B, AlHabib KF, et al. Gender disparities in the presentation, management and outcomes of acute coronary syndrome patients: data from the 2nd Gulf Registry of acute coronary events (Gulf RACE-2). PLoS One 2013;8:e55508.
97. Lu HT, Nordin R, Wan Ahmad WA, et al. Sex differences in acute coronary syndrome in a multiethnic asian population: results of the malaysian national cardiovascular disease databaseacute coronary syndrome (NCVD-ACS) registry. Glob Heart 2014;9:381-90.